NCT05756205

Brief Summary

Pregnancy-related anxiety and depression has received considerable attention worldwide. Mental health problems in pregnant women already since early weeks of gestation may have important consequences for the fetus. Current literature recommends the use of interventions based on new technologies for the treatment of mood disorders, already during the prenatal period. Adult pregnant women (weeks 12-14 of gestation) will be recruited and screened from different primary care centres in Catalonia, Spain. Women who pass the initial mental screening will be randomly allocated to the relaxation virtual reality intervention or control group. The intervention aims to improve mental state of pregnant women during pregnancy, work through breathing, mindfulness and muscle relaxation techniques.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 6, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 6, 2023

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

February 8, 2023

Last Update Submit

February 23, 2023

Conditions

Keywords

PregnancyAnxietyDepressionVirtual RealityMidwifery

Outcome Measures

Primary Outcomes (2)

  • Depression in pregnand women

    Edingburg depression Scale (\>9)

    6 weeks

  • Anxiety in pregnand women

    State trait anxiety inventory (\>75%)

    6 weeks

Secondary Outcomes (1)

  • Symptom checklist -90-R

    6 weeks

Study Arms (2)

Virtual Reality

EXPERIMENTAL

The intervention will consist of an Immersive Virtual Reality (IVR) application with virtual reality goggles Oculus GO, to reduce anxiety during pregnancy. This application lasts 14 minutes by the use of mindfulness techniques based on breathing, mindfulness and passive muscle relaxation.

Device: Immersive Virtual Reality (IVR)

Routine care

NO INTERVENTION

The control group will receive the usual follow-up pregnancy monitoring, without the e-health intervention.

Interventions

The intervention will consist of an Immersive Virtual Reality (IVR) application with virtual reality goggles Oculus GO, to reduce anxiety during pregnancy. This application lasts 14 minutes by the use of mindfulness techniques based on breathing, mindfulness and passive muscle relaxation. It consists of three modules that can be chosen completely or separately. The aspects that conform this intervention will be: information about, the most common perinatal mental health problems, exercises based on attention to breathing (mindfulness-relaxation), 6 weeks of duration, for 14 minutes a day, knowledge from involved personnel of the number of times the woman has connected and the time she has done the exercise, satisfaction questions to pregnant women after pregnancy, alerts to notify the principal investigator if there is a problem with e-health, and, finally, an email address to contact the principal investigator.

Virtual Reality

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women who control their pregnancy in the primary care centers of the Sexual and Reproductive Health Care (ASSIR; Atención a la Salut Sexual i Reproductiva) of Mutua Terrassa, Barcelona (Spain)
  • The women must present a positive value in the mental health screening performed at the beginning of the pregnancy (weeks 12-14 of gestation).
  • Verbal and written literacy understanding of Spanish
  • ≥18 years old.

You may not qualify if:

  • Women with diagnosed psychiatric pathology who are already being followed by the mental health team
  • Women victims of gender-based violence who tested positive in the partner violence screen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fundació Assitencial Mutua Terrassa

Terrassa, Barcelona, 08221, Spain

RECRUITING

Hospital Universitari Mútua Terrassa

Terrassa, Barcelona, 08221, Spain

RECRUITING

Related Publications (2)

  • Jimenez-Barragan M, Del Pino Gutierrez A, Sauch Valmana G, Monistrol O, Monge Marcet C, Pallarols Badia M, Garrido I, Carmona Ruiz A, Porta Roda O, Esquinas C, Falguera Puig G. Immersive Virtual Reality eHealth Intervention to Reduce Anxiety and Depression in Pregnant Women: Randomized Controlled Trial. JMIR Hum Factors. 2025 Apr 30;12:e71708. doi: 10.2196/71708.

  • Jimenez-Barragan M, Del Pino Gutierrez A, Garcia JC, Monistrol-Ruano O, Coll-Navarro E, Porta-Roda O, Falguera-Puig G. Study protocol for improving mental health during pregnancy: a randomized controlled low-intensity m-health intervention by midwives at primary care centers. BMC Nurs. 2023 Sep 7;22(1):309. doi: 10.1186/s12912-023-01440-4.

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Marta Jimenez Barragan, RN, RM

    Fundació Assistencial Mutua Terrassa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marta Jimenez Barragan, RN, RM

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a two-arm prospective, randomized, parallel-controlled clinical trial. 150 women will be recruited and screened during their pregnancy
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2023

First Posted

March 6, 2023

Study Start

December 1, 2022

Primary Completion

February 1, 2024

Study Completion

December 30, 2024

Last Updated

March 6, 2023

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations